Is it safe?
Can WST take a bad year?
West Pharmaceutical Services holds $319M more cash than debt, so a bad year is a question about profits, not about lenders.
$319M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 16.42
Altman Z-score · safe zone, above 3
- Interest cover
- 328×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ1 2026
- $203M
- Cash and short-term investments
- $521M
- Net cash
- $319M
- EBITDA, trailing twelve months
- $830M
- Operating profit, trailing twelve months
- $655M
- Debt / equity
- 0.07×
- Total debt / EBITDA
- 0.24×
- Annualised volatilitytwo years of daily moves
- 47%
- Worst drawdown on file
- −59%
- Below its 52-week high
- −3.4%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #4 of 27 by Smart Score